Keyphrases
Colorectal Cancer
100%
Surveillance Colonoscopy
100%
Cross-sectional Cohort Study
100%
Stool Test
100%
Colonoscopy
60%
Netherlands
40%
Molecular Diagnostics
40%
Screening Program
40%
Adenoma
40%
Fecal Immunochemical Test
40%
Surveillance Strategy
40%
Dutch
20%
High Cost
20%
European Countries
20%
Health Effects
20%
Cost-effectiveness
20%
Stool
20%
Stool Samples
20%
Treatment Burden
20%
Surveillance Program
20%
Colonoscopy Surveillance
20%
Cancer Mortality
20%
Health Costs
20%
Test Sensitivity
20%
Colorectal Cancer Screening
20%
Non-invasive Test
20%
Advanced Adenoma
20%
Stool DNA Test
20%
Test Specificity
20%
Performance Characteristics
20%
Mortality Reduction
20%
Nationwide Screening
20%
Multiple Centers
20%
Logistics Demand
20%
Serrated Pathway
20%
Cologuard
20%
Multitarget Stool DNA
20%
Polyps
20%
Metachronous Colorectal Neoplasia
20%
Medicine and Dentistry
Cohort Analysis
100%
Colonoscopy
100%
Colorectal Carcinoma
100%
Adenoma
50%
Health Care Cost
33%
Screening
33%
Occult Blood Test
33%
Sensitivity and Specificity
16%
Cost-Effectiveness Analysis
16%
Side Effect
16%
Colorectal Tumor
16%
Polyp
16%
Lifespan
16%
Cancer Epidemiology
16%
Study Subject
16%
Health Survey
16%
INIS
testing
100%
surveillance
100%
cancer
54%
cost
27%
adenomas
27%
screening
18%
patients
18%
demand
18%
netherlands
18%
detection
9%
reduction
9%
specificity
9%
sensitivity
9%
mortality
9%
risks
9%
removal
9%
side effects
9%
yields
9%
dna
9%
populations
9%
performance
9%
prediction
9%
solids
9%
lifetime
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Colorectal Carcinoma
100%
Adenoma
50%
Side Effect
16%
Colorectal Tumor
16%
Polyp
16%
Health Survey
16%
Cancer Epidemiology
16%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Screening
100%
Lifespan
50%